Clinical Trial Update: DFN-02 Open Label Safety Study in Patients With Acute Migraine [Phase 3]

View source ↗

Summary

Open-label Phase 3 safety study of DFN-02 in patients with acute migraine has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• DFN-02

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Acute Migraine | Phase 3 | Status: COMPLETED | Results posted: 2017-08-28